Alkermes ALKS
NASDAQ ALKS
$45.40 -0.09 (-0.20%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alkermes (ALKS) Other Working Capital Changes (2017 - 2025)

Alkermes' (ALKS) quarterly Other Working Capital Changes came in at -$2.9 million in Q2 2026, down 11.55% year-over-year from -$3.3 million in Q2 2025, and down 4.15% quarter-over-quarter from -$2.8 million in Q1 2026.

Analysis

Alkermes (ALKS) Other Working Capital Changes (2017 - 2025) Analysis & Trends

Alkermes (ALKS) has reported Other Working Capital Changes for 16 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes fell 11.55% year-over-year to -$2.9 million in Q2 2026; TTM through Jun 2026 was -$10.8 million, a 6.2% decrease from a year earlier, with the FY2025 full-year figure at -$10.3 million, down 1.95% from the prior year.
  • Other Working Capital Changes was -$2.9 million for Q2 2026 at Alkermes, down from -$2.8 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $2.1 million in Q4 2022 and troughed at -$5.1 million in Q3 2022.
  • A 5-year average of -$1.3 million and a median of -$1.1 million in 2024 frame the typical range for Other Working Capital Changes.
  • Across the five-year window, Other Working Capital Changes sank 363.7% in 2022 and jumped 81.94% in 2023, its largest moves.
  • Over 5 years, Other Working Capital Changes stood at -$19.8 million in 2022, then jumped by 81.94% to -$3.6 million in 2023, then gained by 29.32% to -$2.5 million in 2024, then decreased by 2.29% to -$2.6 million in 2025, then dropped by 11.64% to -$2.9 million in 2026.
  • The last three Other Working Capital Changes figures came in at -$2.9 million (Q2 2026), -$2.8 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Alkermes 7.58 Bn 6.92 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -578,000.00
Sep 30, 2025 -578,000.00
Jun 30, 2025 -1.03 Mn
Jun 30, 2025 -1.03 Mn
Mar 31, 2025 359,000.00
Mar 31, 2025 359,000.00
Dec 31, 2024 -1.09 Mn
Dec 31, 2024 -1.09 Mn
Sep 30, 2024 -972,000.00
Sep 30, 2024 -972,000.00
Jun 30, 2024 -1.26 Mn
Jun 30, 2024 -1.26 Mn
Mar 31, 2024 -208,000.00
Mar 31, 2024 -208,000.00
Dec 31, 2023 -202,000.00
Dec 31, 2023 -202,000.00
Sep 30, 2023 -692,000.00
Sep 30, 2023 -692,000.00
Jun 30, 2023 -745,000.00
Jun 30, 2023 -745,000.00